E. Galossi

Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis

M. Voso, R. Latagliata, M. Pieraccioli, 2022, Scientific reports.

New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia.

M. Voso, A. Fiore, F. Pane, 2023, Current research in translational medicine.

Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes.

M. Voso, E. Fabiani, G. Falconi, 2023, Inflammation research : official journal of the European Histamine Research Society ... [et al.].

Microenvironment in Acute Myeloid Leukemia: focus on senescence mechanisms, therapeutic interactions and future directions.

M. Voso, E. Fabiani, G. Falconi, 2023, Experimental hematology.

Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort

M. Voso, A. Tomelleri, C. Campochiaro, 2023, American journal of hematology.